Safety and Effectiveness of Molnupiravir in Japanese Patients with COVID-19: Final Report of Post-marketing Surveillance in Japan
- DOI
- 10.1007/s40121-023-00915-w
- Published
- 2024-01
- Container
- Infectious Diseases and Therapy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s40121-023-00915-w,
title = {Safety and Effectiveness of Molnupiravir in Japanese Patients with COVID-19: Final Report of Post-marketing Surveillance in Japan},
author = {Shohei Shinozaki and Asuka Watanabe and Masahiro Kimata and Makoto Miyazaki and Shinichiroh Maekawa},
year = {2024},
journal = {Infectious Diseases and Therapy},
doi = {10.1007/s40121-023-00915-w},
url = {https://doi.org/10.1007/s40121-023-00915-w}
}RIS
TY - JOUR TI - Safety and Effectiveness of Molnupiravir in Japanese Patients with COVID-19: Final Report of Post-marketing Surveillance in Japan AU - Shohei Shinozaki AU - Asuka Watanabe AU - Masahiro Kimata AU - Makoto Miyazaki AU - Shinichiroh Maekawa PY - 2024 JO - Infectious Diseases and Therapy DO - 10.1007/s40121-023-00915-w UR - https://doi.org/10.1007/s40121-023-00915-w ER -
APA
Shinozaki, S., Watanabe, A., Kimata, M., Miyazaki, M., & Maekawa, S. (2024). Safety and Effectiveness of Molnupiravir in Japanese Patients with COVID-19: Final Report of Post-marketing Surveillance in Japan. Infectious Diseases and Therapy. https://doi.org/10.1007/s40121-023-00915-w
Source records
- crossref · retrieved 2026-09-26T22:48:16.157Z